Cargando…

Identifying risk factors for in-stent restenosis in symptomatic intracranial atherosclerotic stenosis: a systematic review and meta-analysis

BACKGROUND: In-stent restenosis (ISR) is an adverse and notable event in the treatment of intracranial atherosclerotic stenosis (ICAS) with percutaneous transluminal angioplasty and stenting (PTAS). The incidence and contributing factors have not been fully defined. This study was performed to evalu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ning, Lu, Yuning, Feng, Lei, Lin, Dongdong, Gao, Yuhai, Wu, Jiong, Wang, Ming, Wan, Shu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375724/ https://www.ncbi.nlm.nih.gov/pubmed/37521300 http://dx.doi.org/10.3389/fneur.2023.1170110

Ejemplares similares

Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China
por: Guo, Xu, et al.
Publicado: (2021)

Corrigendum: Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China
por: Guo, Xu, et al.
Publicado: (2021)

Functional evaluation of intracranial atherosclerotic stenosis by pressure ratio measurements
por: Wang, Ming, et al.
Publicado: (2023)

Feasibility and Safety of Paclitaxel-Coated Balloon Angioplasty for the Treatment of Intracranial Symptomatic In-Stent Restenosis
por: Xu, Haowen, et al.
Publicado: (2020)

Hemodynamic and Geometric Risk Factors for In-Stent Restenosis in Patients with Intracranial Atherosclerotic Stenosis
por: Song, Xiaowen, et al.
Publicado: (2022)

Enterprise stent for symptomatic complex intracranial atherosclerotic stenosis: safety and efficiency
por: Dong, Yanhua, et al.
Publicado: (2019)

Complications and long-term in-stent restenosis of endovascular treatment of severe symptomatic intracranial atherosclerotic stenosis and relevant risk factors
por: Yang, Lei, et al.
Publicado: (2023)

Balloon Angioplasty vs. Stenting for Symptomatic Intracranial Arterial Stenosis
por: Sun, Yaxuan, et al.
Publicado: (2022)

Intracranial angioplasty with a self-expandable stent for intracranial atherosclerotic stenosis: Systematic review and meta-analysis
por: Zhong, Cai, et al.
Publicado: (2023)

Plaque Characteristics in Young Adults With Symptomatic Intracranial Atherosclerotic Stenosis: A Preliminary Study
por: Li, Ling, et al.
Publicado: (2022)

Neovascularization in Human Intracranial Atherosclerotic In-Stent Restenosis
por: Feng, Yiding, et al.
Publicado: (2021)

Predictors of hyperperfusion syndrome after stent implantation in symptomatic intracranial atherosclerotic stenosis
por: Yan, Long, et al.
Publicado: (2022)

Protocol for a prospective, multicentre registry study of stenting for symptomatic intracranial artery stenosis in China
por: Wang, Yilong, et al.
Publicado: (2014)

Intervals of endovascular treatment for coincidental non-adjacent unruptured aneurysms in patients with symptomatic intracranial atherosclerotic stenosis
por: Jin, Hengwei, et al.
Publicado: (2022)

Blood biomarkers of progressive atherosclerosis and restenosis after stenting of symptomatic intracranial artery stenosis
por: Haidegger, Melanie, et al.
Publicado: (2021)

Effect of a Drug-Eluting Stent vs. Bare Metal Stent for the Treatment of Symptomatic Intracranial and Vertebral Artery Stenosis
por: Si, Jiang-Hua, et al.
Publicado: (2022)

Stenting for Symptomatic Intracranial Vertebrobasilar Artery Stenosis in Northeast of China: A Single-Center Study
por: Wang, Zhongxiu, et al.
Publicado: (2021)

Stroke recurrence is associated with unfavorable intracranial venous outflow in patients with symptomatic intracranial atherosclerotic large vessel severe stenosis or occlusion
por: Gao, Jiali, et al.
Publicado: (2023)

Initial Experience With the Next-Generation Resolute Onyx Zotarolimus-Eluting Stent in Symptomatic Intracranial Atherosclerotic Disease
por: Hassan, Ameer E., et al.
Publicado: (2020)

Baseline vessel wall magnetic resonance imaging characteristics associated with in-stent restenosis for intracranial atherosclerotic stenosis
por: Tian, Bing, et al.
Publicado: (2023)

The Enterprise2 Stent for Endovascular Treatment of Intracranial Aneurysms: Short-Term Results From a Single Center Experience
por: Chen, Linhui, et al.
Publicado: (2020)

Factors affecting in-stent restenosis after angioplasty with the Enterprise stent for intracranial atherosclerotic diseases
por: Zhang, Kun, et al.
Publicado: (2021)

Associations of neutrophil-to-lymphocyte ratio with intracranial and extracranial atherosclerotic stenosis
por: Xie, Yu, et al.
Publicado: (2022)

Enterprise stent for the treatment of symptomatic intracranial atherosclerotic stenosis: an initial experience of 44 patients
por: Feng, Zhengzhe, et al.
Publicado: (2015)

Intra-Arterial Glycoprotein IIb/IIIa Inhibitor Treatment for Symptomatic Intracranial Atherosclerotic Stenosis Presenting as Large Vessel Occlusions
por: Srivatsan, Aditya, et al.
Publicado: (2020)

Serum Bilirubin Levels and Extent of Symptomatic Intracranial Atherosclerotic Stenosis in Acute Ischemic Stroke: A Cross-Sectional Study
por: Yu, Fang, et al.
Publicado: (2021)

Coronary Stent for Right Transverse Venous Sinus Stenosis in a Patient With Symptomatic Idiopathic Intracranial Hypertension
por: Perdomo Luna, Camilo A, et al.
Publicado: (2023)

Endovascular Treatment of Intracranial Atherosclerotic Stenosis: Current Debates and Future Prospects
por: Luo, Jichang, et al.
Publicado: (2018)

Factors Influencing the Outcome of Symptomatic Intracranial Artery Stenosis With Hemodynamic Impairment After Short and Long-Term Stent Placement
por: Gong, Wentao, et al.
Publicado: (2022)

Peri-therapeutic multi-modal hemodynamic assessment and detection of predictors for symptomatic in-stent restenosis after percutaneous transluminal angioplasty and stenting
por: Song, Xiaowen, et al.
Publicado: (2023)

Effects of stent shape on focal hemodynamics in intracranial atherosclerotic stenosis: A simulation study with computational fluid dynamics modeling
por: Liu, Haipeng, et al.
Publicado: (2022)

A retrospective study of individualized endovascular treatment for symptomatic intracranial atherosclerotic stenosis in patients with ischemic stroke/transient ischemic attack
por: Mao, Lun-Lin, et al.
Publicado: (2022)

Neuroform EZ Stenting for Symptomatic Intracranial Artery Stenosis: 30 Days Outcomes in a High-Volume Stroke Center
por: Xu, Haowen, et al.
Publicado: (2019)

Stenting versus medical therapy alone for symptomatic intracranial arterial stenosis: protocol for a systematic review and individual patient data meta-analysis
por: Wang, Tao, et al.
Publicado: (2023)

Associations of Monocytes and the Monocyte/High-Density Lipoprotein Ratio With Extracranial and Intracranial Atherosclerotic Stenosis
por: Liu, Zhu, et al.
Publicado: (2021)

Is the future of symptomatic intracranial atherosclerotic stenosis management promising?
por: Liu, Dacheng, et al.
Publicado: (2020)

Long-term outcome and factors associated with restenosis after combination therapy of balloon angioplasty and stenting for symptomatic intracranial stenosis
por: Ueda, Toshihiro, et al.
Publicado: (2022)

Outcome of Wingspan Stent Using Aggressive Post-stent Balloon Dilation for Intracranial Atherosclerosis Stenosis
por: Perng, Pang-Shuo, et al.
Publicado: (2021)

Mechanical thrombectomy first versus direct angioplasty or stenting for the treatment of intracranial atherosclerotic stenosis-related large vessel occlusion: protocol for a systematic review and meta-analysis
por: Min, Xiaoli, et al.
Publicado: (2022)

A non-linear relationship between lesion length and risk of recurrent cerebral ischemia after stenting for symptomatic intracranial stenosis with hemodynamic impairment
por: Zhang, Xianjun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eb7aqfjjrc7m544p72mkfrm93i